1. Home
  2. MYSZ vs INM Comparison

MYSZ vs INM Comparison

Compare MYSZ & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo My Size Inc.

MYSZ

My Size Inc.

HOLD

Current Price

$0.54

Market Cap

2.5M

Sector

Technology

ML Signal

HOLD

Logo InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc.

HOLD

Current Price

$1.55

Market Cap

2.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYSZ
INM
Founded
1999
1981
Country
Israel
Canada
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5M
2.1M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
MYSZ
INM
Price
$0.54
$1.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
57.4K
3.0M
Earning Date
04-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
57.40
N/A
EPS
N/A
N/A
Revenue
$142,000.00
$4,942,633.00
Revenue This Year
$41.64
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
125.40
7.50
52 Week Low
$0.48
$0.58
52 Week High
$1.65
$3.34

Technical Indicators

Market Signals
Indicator
MYSZ
INM
Relative Strength Index (RSI) 46.77 72.16
Support Level $0.52 $1.56
Resistance Level $0.68 $1.95
Average True Range (ATR) 0.05 0.17
MACD 0.01 0.01
Stochastic Oscillator 33.17 71.48

Price Performance

Historical Comparison
MYSZ
INM

About MYSZ My Size Inc.

My Size Inc is a fashion technology company operating an integrated portfolio of businesses designed to address the pressing challenges facing fashion brands and retailers today - size and fit accuracy, excess inventory management, circular economy solutions, and international market distribution. The company, through its subsidaries provide end-to-end support across the fashion value chain; delivers AI-driven size and fit solutions for fashion e-commerce companies. The firm has the following four segments: (i) Fashion e-commerce platform, (ii) SaaS solutions, (iii) resale platform for apparel, and (iv) wholesaling of footwear. The company generates the majority of its revenue from the fashion e-commerce platform segment.

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

Share on Social Networks: